Indications

Revium’s proprietary drug delivery platform for enhanced therapeutics integrates clinically-proven nanoparticles, a proprietary drug loading and release technology, and specialized lipid-based micro particles carrier compositions.

Our Pipeline

Program
Indication
Lead Optimization
IND Enabling Studies
Phase I
Nano-
Mupirocin
Resistant
Bacterial
Infections
Nano-
Mupirocin
Fungal
Infections
Nano-
Candesartan
Cancer
Therapy